Valuation Alaunos Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 00:30:00 09/09/2026 +04			5-day change	1st Jan Change
1.570 ^USD	-3.68%		-5.42%	-51.39%

08-15	Alaunos Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-29	Alaunos Therapeutics Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment For Body Fat Percentage In 48-Day DIO Mouse Study	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	536.6	234	155.4	16.98	3.05	7.209
Change	-	-56.4%	-33.56%	-89.08%	-82.04%	136.32%
Enterprise Value (EV) ¹	426.3	187.3	135.9	10.92	1.959	5.824
Change	-	-56.08%	-27.43%	-91.96%	-82.06%	197.23%
P/E	-6.61x	-2.97x	-3.74x	-0.48x	-0.65x	-1.47x
PBR	4.35x	4.04x	4.03x	2.69x	1.48x	3.52x
PEG	-	0.8x	0.1x	0x	0x	0.1x
Capitalization / Revenue	-	587,819,588x	53,196,617x	3,396,281,000x	305,038,500x	1,441,761,400x
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-5.38x	-2.52x	-4.53x	-0.42x	-0.41x	-1.38x
EV / EBIT	-5.31x	-2.44x	-4.15x	-0.38x	-0.41x	-1.38x
EV / FCF	-11.8x	-5.36x	-4.86x	-2.14x	-0.59x	-7.73x
FCF Yield	-8.45%	-18.7%	-20.6%	-46.7%	-168%	-12.9%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-57.22	-55.1	-26.06	-22	-2.922	-2.198
Distribution rate	-	-	-	-	-	-
Net sales	-	0.398	2.922	0.005	0.01	0.005
EBITDA ¹	-79.23	-74.21	-29.98	-26.18	-4.81	-4.218
EBIT ¹	-80.36	-76.81	-32.74	-28.49	-4.812	-4.225
Net income ¹	-79.98	-78.75	-37.73	-35.14	-4.679	-4.176
Net Debt ¹	-110.3	-46.69	-19.55	-6.062	-1.091	-1.385
Reference price ²	378.000	163.500	97.365	10.605	1.905	3.230
Nbr of stocks (in thousands)	1,420	1,431	1,596	1,601	1,601	2,232
Announcement Date	01/03/21	30/03/22	07/03/23	01/04/24	31/03/25	31/03/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALAUNOS THERAPEUTICS, INC.	-	-	-	-	3.99M
WUXI APPTEC CO., LTD.	20.31x	7.19x	14.43x	1.46%	69.19B
ARGENX SE	35.78x	9.33x	28.47x	0.04%	62.97B
INSMED INCORPORATED	-76.45x	14.75x	-71.13x	-.--%	27.27B
BIONTECH SE	-14.89x	5.5x	-6.92x	-.--%	24.78B
WUXI BIOLOGICS (CAYMAN) INC.	29.76x	6.36x	16.51x	-.--%	25.8B
GENMAB A/S	27.41x	5.13x	17.28x	-.--%	20.11B
PHARMAESSENTIA CORPORATION	52.99x	19.62x	39.8x	0.28%	18.47B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1285.53x	37.11x	809.82x	-.--%	14.88B
EXELIXIS, INC.	17.81x	5.31x	12.39x	-.--%	14.29B
Average	153.14x	12.26x	95.63x	0.2%	27.78B
Weighted average by Cap.	82.37x	10.37x	51.89x	0.39%